Neurology
Partner With Us
Advertisement
Conexiant chevron_right Neurology chevron_right FDA Approves First New Stroke Thrombolytic in 30 Years
FDA & Government News

FDA Approves First New Stroke Thrombolytic in 30 Years

The FDA has approved tenecteplase for acute ischemic stroke, offering a faster and simpler administration compared to alteplase based on findings from the AcT trial.

Conexiant
article Full Article subject Summary summarize Notecard
  1. FDA has approved TNKase for acute ischemic stroke treatment.
  2. TNKase offers a simplified and faster administration alternative to alteplase.
  3. AcT trial demonstrated TNKase's efficacy in treating AIS patients.
  4. Genentech, the developer of TNKase, plans to introduce a new vial configuration to support use in stroke management.

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.